Your browser doesn't support javascript.
loading
Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.
Fasler-Kan, Elizaveta; Milosevic, Milan; Ruggiero, Sabrina; Aliu, Nijas; Cholewa, Dietmar; Häcker, Frank-Martin; Dekany, Gabriela; Bartenstein, Andreas; Berger, Steffen M.
Afiliação
  • Fasler-Kan E; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Milosevic M; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Ruggiero S; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Aliu N; Department of Human Genetics, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Cholewa D; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Häcker FM; Department of Pediatric Surgery, Children's Hospital of Eastern Switzerland, CH-9000 St. Gallen, Switzerland.
  • Dekany G; Faculty of Medicine, University of Basel, CH-4031 Basel, Switzerland.
  • Bartenstein A; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
  • Berger SM; Department of Pediatric Surgery, Children's Hospital, Inselspital Bern, University of Bern, CH-3010 Bern, Switzerland.
Int J Mol Sci ; 25(4)2024 Feb 14.
Article em En | MEDLINE | ID: mdl-38396958
ABSTRACT
Renal tumors comprise ~7% of all malignant pediatric tumors. Approximately 90% of pediatric kidney tumors comprise Wilms tumors, and the remaining 10% include clear cell sarcoma of the kidney, malignant rhabdoid tumor of the kidney, renal cell carcinoma and other rare renal tumors. Over the last 30 years, the role of cytokines and their receptors has been considerably investigated in both cancer progression and anti-cancer therapy. However, more effective immunotherapies require the cytokine profiling of each tumor type and comprehensive understanding of tumor biology. In this study, we aimed to investigate the activation of signaling pathways in response to cytokines in three pediatric kidney tumor cell lines, in WT-CLS1 and WT-3ab cells (both are Wilms tumors), and in G-401 cells (a rhabdoid kidney tumor, formerly classified as Wilms tumor). We observed that interferon-alpha (IFN-α) and interferon-gamma (IFN-γ) very strongly induced the activation of the STAT1 protein, whereas IL-6 and IFN-α activated STAT3 and IL-4 activated STAT6 in all examined tumor cell lines. STAT protein activation was examined by flow cytometry and Western blot using phospho-specific anti-STAT antibodies which recognize only activated (phosphorylated) STAT proteins. Nuclear translocation of phospho-STAT proteins upon activation with specific cytokines was furthermore confirmed by immunofluorescence. Our results also showed that both IFN-α and IFN-γ caused upregulation of major histocompatibility complex (MHC) class I proteins, however, these cytokines did not have any effect on the expression of MHC class II proteins. We also observed that pediatric kidney tumor cell lines exhibit the functional expression of an additional cytokine signaling pathway, the tumor necrosis factor (TNF)-α-mediated activation of nuclear factor kappa B (NF-κB). In summary, our data show that human pediatric renal tumor cell lines are responsive to stimulation with various human cytokines and could be used as in vitro models for profiling cytokine signaling pathways.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Neoplasias Renais Limite: Child / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Neoplasias Renais Limite: Child / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça